Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
CALL
Ingersoll Rand
IR
$34.4B
| $14M | ﹤0.01% |
+170,000
| New | +$13.9M |
|
1427
Coursera
COUR
$1.59B
| $14M | ﹤0.01% |
1,195,427
-76,215
| -6% | -$828K |
|
1428
Liberty Global Class A
LBTYA
$3.69B
| $14M | ﹤0.01% |
1,220,361
-484,450
| -28% | -$5.33M |
|
1429
Avantor
AVTR
$8.93B
| $13.9M | ﹤0.01% |
1,117,158
-2,008,122
| -64% | -$25.9M |
|
1430
PUT
BHP
BHP
$224B
| $13.9M | ﹤0.01% |
+250,000
| New | +$13.3M |
|
1431
Tradeweb Markets
TW
$21.7B
| $13.9M | ﹤0.01% |
125,547
+11,823
| +10% | +$1.52M |
|
1432
Burford Capital
BUR
$953M
| $13.9M | ﹤0.01% |
1,162,426
-712,670
| -38% | -$9.53M |
|
|
GTM
1433
ZoomInfo Technologies
GTM
$1.22B
| $13.9M | ﹤0.01% |
1,274,104
-82,328
| -6% | -$883K |
|
1434
Paylocity
PCTY
$8.24B
| $13.9M | ﹤0.01% |
87,220
+19,285
| +28% | +$3.41M |
|
1435
Encore Capital Group
ECPG
$2.11B
| $13.9M | ﹤0.01% |
332,702
+33,350
| +11% | +$1.37M |
|
1436
CALL
Surgery Partners
SGRY
$1.94B
| $13.8M | ﹤0.01% |
640,000
| – | – |
|
1437
Primoris Services
PRIM
$4.43B
| $13.8M | ﹤0.01% |
100,824
-37,085
| -27% | -$3.98M |
|
1438
Lithia Motors
LAD
$8.24B
| $13.8M | ﹤0.01% |
43,773
+7,733
| +21% | +$2.49M |
|
1439
Century Communities
CCS
$1.97B
| $13.8M | ﹤0.01% |
217,100
-28,305
| -12% | -$1.79M |
|
1440
Cullen/Frost Bankers
CFR
$10.3B
| $13.7M | ﹤0.01% |
108,382
+45,469
| +72% | +$5.91M |
|
1441
Stantec
STN
$8.3B
| $13.7M | ﹤0.01% |
127,300
+38,382
| +43% | +$4.19M |
|
1442
Ormat Technologies
ORA
$6.55B
| $13.7M | ﹤0.01% |
142,436
+16,797
| +13% | +$1.52M |
|
1443
ONE Gas
OGS
$5B
| $13.7M | ﹤0.01% |
169,315
+3,268
| +2% | +$245K |
|
1444
UiPath
PATH
$7.14B
| $13.7M | ﹤0.01% |
1,023,915
+817,654
| +396% | +$9.67M |
|
1445
Teva Pharmaceuticals
TEVA
$40.4B
| $13.6M | ﹤0.01% |
675,126
+75,112
| +13% | +$1.32M |
|
1446
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.66B
| $13.6M | ﹤0.01% |
215,400
+40,000
| +23% | +$2.52M |
|
1447
Petrobras Class A
PBR.A
$107B
| $13.6M | ﹤0.01% |
1,153,435
+33,579
| +3% | +$388K |
|
1448
Glacier Bancorp
GBCI
$6.36B
| $13.6M | ﹤0.01% |
279,988
-72,416
| -21% | -$3.39M |
|
1449
Healthcare Realty
HR
$6.96B
| $13.6M | ﹤0.01% |
752,427
-385,003
| -34% | -$6.51M |
|
1450
Revolution Medicines
RVMD
$41.7B
| $13.6M | ﹤0.01% |
290,449
+34,065
| +13% | +$1.33M |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.